Skip to main content
Fig. 1 | Military Medical Research

Fig. 1

From: Regeneration of the heart: from molecular mechanisms to clinical therapeutics

Fig. 1

Standard of care for heart failure. Pharmacological treatment and medical devices are currently being used to manage the progression of diseases. β-blocker, ACEi, MRA, and SGLT2i are usually used for all patients with heart failure in order to reduce mortality. For selected patients, diuretic, ivabradine, and digoxin might be used. For advanced stage patients, device and surgery would be recommended. ACEi angiotensin-converting enzyme inhibitor, ARNi angiotensin receptor neprilysin inhibitor, ARB angiotensin receptor blocker, MRA aldosterone receptor antagonists, SGL2i sodium glucose cotransporter 2 inhibitor, HR heart rate, CRT-P cardiac resynchronization therapy-pacemakers, CRT-D cardiac resynchronization therapy-defibrillators, ICD implantable cardioverter defibrillator, MCS mechanical circulatory support

Back to article page